Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder

Psychiatry Res. 2014 May 15;216(2):286-7. doi: 10.1016/j.psychres.2014.01.049. Epub 2014 Feb 6.

Abstract

We report the case of a 35-year-old patient suffering from schizo-affective disorder since the age of 19 years, treated by a combination of first-generation antipsychotics, zuclopenthixol (100 mg/day) and lithium (1200 mg/day) (serum lithium=0.85 mEq/l). This patient had no associated personality disorder (particularly no antisocial disorder) and no substance abuse disorder. Within the 48 h following the gradual introduction of quetiapine (up to 600 mg/day), the patient presented severe agitation without an environmental explanation, contrasting with the absence of a history of aggressiveness or personality disorder. The diagnoses of manic shift and akathisia were dismissed. The withdrawal and the gradual reintroduction of quetiapine 2 weeks later, which led to another severe agitation, enabled us to attribute the agitation specifically to quetiapine.

Keywords: Aggressiveness; Agitation; Drug interaction; Quetiapine; Schizo-affective disorder.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aggression / drug effects
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Dibenzothiazepines / administration & dosage*
  • Dibenzothiazepines / adverse effects*
  • Dibenzothiazepines / therapeutic use
  • Dyskinesia, Drug-Induced*
  • Humans
  • Male
  • Psychomotor Agitation / physiopathology*
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / physiopathology*
  • Psychotic Disorders / psychology
  • Quetiapine Fumarate

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Quetiapine Fumarate